Medicine
Bimatoprost 0.3 mg/mL eye drops
Bimatoprost 0.3 mg/mL eye drops is a generic prescription medicine for ophthalmic use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 2° to 25°C (36° to 77°F).
Key facts
- Active ingredient (INN)
- Bimatoprost
- Brand
- Sold under the generic name
- Strength
- 0.3 mg/mL
- Dosage form
- Eye drops
- Route
- Ophthalmic
- Packs
- 1 bottle and 26 more
- Manufacturers
- Alembic PharmaceuticalsIndiaAurobindo PharmaIndiaGland PharmaIndiaMicro LabsIndiaFosun PharmaSomerset TherapeuticsApotexNuCare Pharmaceuticals,IncSandoz
- Origin register
- US FDA, United States
- Storage
- Store at 2° to 25°C (36° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01EE03 Bimatoprost
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 December 2016
- Identifiers
- RxCUI 308739, 1041495DailyMed set ID 2a4b5b6b-fc47-40d2-8396-ff60511a4cd1, b2afe664-49b0-4d69-bc89-adddf50b58ba, 2f9ee30a-1737-44b2-8479-79a3ee88bf5b +10NDC 68083-439, 70069-401, 72266-241 +16Application ANDA210126, ANDA207601, ANDA210515 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 5 mL in 1 bottle | 46708-507-05 | Alembic PharmaceuticalsIndia | 12 April 2019 |
| 1 bottle in 1 carton / 2.5 mL in 1 bottle | 46708-507-25 | Alembic PharmaceuticalsIndia | 12 April 2019 |
| 1 bottle in 1 carton / 3 mL in 1 bottle | 46708-511-03 | Alembic PharmaceuticalsIndia | 21 July 2023 |
| 1 bottle in 1 carton / 5 mL in 1 bottle | 46708-511-05 | Alembic PharmaceuticalsIndia | 21 July 2023 |
| 1 bottle in 1 carton / 5 mL in 1 bottle | 62332-507-05 | Alembic PharmaceuticalsIndia | 12 April 2019 |
| 1 bottle in 1 carton / 2.5 mL in 1 bottle | 62332-507-25 | Alembic PharmaceuticalsIndia | 12 April 2019 |
| 1 bottle in 1 carton / 3 mL in 1 bottle | 62332-511-03 | Alembic PharmaceuticalsIndia | 20 March 2020 |
| 1 bottle in 1 carton / 5 mL in 1 bottle | 62332-511-05 | Alembic PharmaceuticalsIndia | 21 January 2020 |
| 1 bottle in 1 carton / 2.5 mL in 1 bottle | 68083-295-01 | Gland PharmaIndia | 12 February 2019 |
| 1 bottle in 1 carton / 5 mL in 1 bottle | 68083-296-01 | Gland PharmaIndia | 12 February 2019 |
| 1 bottle in 1 carton / 7.5 mL in 1 bottle | 68083-439-01 | Gland PharmaIndia | 12 August 2020 |
| 1 bottle in 1 carton / 5 mL in 1 bottle | 65862-802-05 | Aurobindo PharmaIndia | 6 October 2022 |
| 1 bottle in 1 carton / 7.5 mL in 1 bottle | 65862-802-10 | Aurobindo PharmaIndia | 6 October 2022 |
| 1 bottle in 1 carton / 2.5 mL in 1 bottle | 65862-802-44 | Aurobindo PharmaIndia | 6 October 2022 |
| 1 bottle in 1 carton / 5 mL in 1 bottle | 42571-128-21 | Micro LabsIndia | 15 March 2021 |
| 1 bottle in 1 carton / 7.5 mL in 1 bottle | 42571-128-28 | Micro LabsIndia | 15 March 2021 |
| 1 bottle in 1 carton / 2.5 mL in 1 bottle | 42571-128-35 | Micro LabsIndia | 15 March 2021 |
| 1 bottle in 1 carton / 2.5 mL in 1 bottle | 72266-139-01 | Fosun Pharma | 10 August 2020 |
| 1 bottle in 1 carton / 5 mL in 1 bottle | 72266-140-01 | Fosun Pharma | 10 August 2020 |
| 1 bottle in 1 carton / 7.5 mL in 1 bottle | 72266-241-01 | Fosun Pharma | 30 November 2025 |
| 1 bottle in 1 carton / 2.5 mL in 1 bottle | 70069-401-01 | Somerset Therapeutics | 19 June 2019 |
| 1 bottle in 1 carton / 5 mL in 1 bottle | 70069-402-01 | Somerset Therapeutics | 19 June 2019 |
| 1 bottle in 1 carton / 7.5 mL in 1 bottle | 70069-403-01 | Somerset Therapeutics | 19 June 2019 |
| 1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper | 60505-0583-1 | Apotex | 8 October 2018 |
| 1 bottle, dropper in 1 carton / 2.5 mL in 1 bottle, dropper | 60505-0583-4 | Apotex | 8 October 2018 |
| 1 bottle, with applicator in 1 carton / 5 mL in 1 bottle, with applicator | 0781-6206-75 | Sandoz | 6 December 2016 |
| 1 bottle, with applicator in 1 carton / 3 mL in 1 bottle, with applicator | 0781-6206-93 | Sandoz | 6 December 2016 |
| 1 bottle in 1 carton / 2.5 mL in 1 bottle | 68071-3590-5 | NuCare Pharmaceuticals,Inc | 25 March 2024 |
| 1 bottle in 1 carton / 2.5 mL in 1 bottle | 68071-3612-5 | NuCare Pharmaceuticals,Inc | 30 May 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Bimatoprost 0.3 mg/mL eye drops.
Other strengths and forms of Bimatoprost
Clinical summary
Bimatoprost is a prostaglandin analog indicated to treat hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness. It is available as eye drops, implants and ophthalmic gel for intracameral use. MedsAcross supplies Bimatoprost for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BimatoprostFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- LATISSE prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
- Lumigan: European public assessment report (EPAR) · European Medicines Agency
Need Bimatoprost 0.3 mg/mL eye drops for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.